Department of Critical Care, Radboud University Medical Center, Nijmegen, The Netherlands.
Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Crit Care Med. 2022 Jan 1;50(1):e1-e10. doi: 10.1097/CCM.0000000000005216.
Obesity is a risk factor for severe coronavirus disease 2019 and might play a role in its pathophysiology. It is unknown whether body mass index is related to clinical outcome following ICU admission, as observed in various other categories of critically ill patients. We investigated the relationship between body mass index and inhospital mortality in critically ill coronavirus disease 2019 patients and in cohorts of ICU patients with non-severe acute respiratory syndrome coronavirus 2 viral pneumonia, bacterial pneumonia, and multiple trauma.
Multicenter observational cohort study.
Eighty-two Dutch ICUs participating in the Dutch National Intensive Care Evaluation quality registry.
Thirty-five-thousand five-hundred six critically ill patients.
None.
Patient characteristics and clinical outcomes were compared between four cohorts (coronavirus disease 2019, nonsevere acute respiratory syndrome coronavirus 2 viral pneumonia, bacterial pneumonia, and multiple trauma patients) and between body mass index categories within cohorts. Adjusted analyses of the relationship between body mass index and inhospital mortality within each cohort were performed using multivariable logistic regression. Coronavirus disease 2019 patients were more likely male, had a higher body mass index, lower Pao2/Fio2 ratio, and were more likely mechanically ventilated during the first 24 hours in the ICU compared with the other cohorts. Coronavirus disease 2019 patients had longer ICU and hospital length of stay, and higher inhospital mortality. Odds ratios for inhospital mortality for patients with body mass index greater than or equal to 35 kg/m2 compared with normal weight in the coronavirus disease 2019, nonsevere acute respiratory syndrome coronavirus 2 viral pneumonia, bacterial pneumonia, and trauma cohorts were 1.15 (0.79-1.67), 0.64 (0.43-0.95), 0.73 (0.61-0.87), and 0.81 (0.57-1.15), respectively.
The obesity paradox, which is the inverse association between body mass index and mortality in critically ill patients, is not present in ICU patients with coronavirus disease 2019-related respiratory failure, in contrast to nonsevere acute respiratory syndrome coronavirus 2 viral and bacterial respiratory infections.
肥胖是严重 2019 冠状病毒病(coronavirus disease 2019,COVID-19)的危险因素,可能在其病理生理学中发挥作用。但 ICU 收治的 COVID-19 患者的临床结局是否与其他危重症患者一样与体重指数(body mass index,BMI)相关,目前尚不清楚。我们调查了 BMI 与 COVID-19 危重症患者院内死亡率之间的关系,并与非严重急性呼吸综合征冠状病毒 2(severe acute respiratory syndrome coronavirus 2,SARS-CoV-2)病毒性肺炎、细菌性肺炎和多发创伤的 ICU 患者队列进行了比较。
多中心观察性队列研究。
参与荷兰国家重症监护评估质量登记处的 82 家荷兰 ICU。
3506 例危重症患者。
无。
在 COVID-19 患者、非 SARS-CoV-2 病毒性肺炎患者、细菌性肺炎患者和多发创伤患者 4 个队列中比较了患者特征和临床结局,并在队列内比较了 BMI 类别。采用多变量逻辑回归对每个队列内 BMI 与院内死亡率的关系进行了调整分析。与其他队列相比,COVID-19 患者更可能为男性,BMI 更高,动脉血氧分压/吸入氧分数(Pao2/Fio2)比值更低,并且在 ICU 入住的前 24 小时内更可能需要机械通气。COVID-19 患者 ICU 入住时间和住院时间更长,院内死亡率更高。与 COVID-19 患者的正常体重相比,BMI 大于或等于 35kg/m2 的患者院内死亡率的优势比分别为 1.15(0.79-1.67)、0.64(0.43-0.95)、0.73(0.61-0.87)和 0.81(0.57-1.15)。
肥胖悖论是指危重症患者 BMI 与死亡率呈反比关系,而在 COVID-19 相关呼吸衰竭的 ICU 患者中并未出现这种情况,这与非 SARS-CoV-2 病毒性和细菌性呼吸道感染不同。